Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization

Fertility and Sterility

Volumn 68, Issue 2, 1997, Pages 305-311

  Lee, Annette ^a   Burry, Kenneth A ^a   Christenson, Lane K ^b   Patton, Phillip E ^a   Stouffer, Richard L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

FF; Granulosa cells; IVF; OHSS; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; ASCITES FLUID ANALYSIS; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; CORPUS LUTEUM FUNCTION; ELECTROLYTE DISTURBANCE; FEMALE; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; LUTEINIZATION; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; VASCULARIZATION;

EID: 0342618534     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81520-8     Document Type: Article

References (13)

1. Ferrera N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the VEGF family of proteins. Endocr Rev 1992;1:18-32.
2. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of VPF/VEGF by human granulosa and theca lutean cells: role in corpus luteum development. Am J Pathol 1995;146:157-65.
3. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996;81:353-9.
4. Lee A, Christenson LK, Stouffer RL, Burry KA, Patton PE. Gonadotropin vs. progesterone regulation of vascular endothelial growth factor production by luteinized human granulosa cells. J Soc Gynecol Invest 1997;4(1 Suppl):237A.
5. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, et al. HCG dependent expression of VEGF/VPF in human granulosa cells: importance in OHSS. J Clin Endocrinol Metab 1995;80:1967-71.
6. Brisden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995; 102:767-72.
7. Patton PE, Eaton D, Burry KA, Wolf DP. The use of gonado-tropin-releasing hormone agonist to regulate oocyte retrieval time. Fertil Steril 1990;64:652-5.
8. Sauer MV. Oocyte donation to women of advanced reproductive age. Semin Reprod Endocrinol 1995;13:231-6.
9. Hess DL, Spies HG, Hendricks AG. Diurnal steroid patterns during gestation in the rhesus macaque: onset, daily variation and the effects of dexamethasone treatment. Biol Reprod 1981;24:609-16.
10. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo KT. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation: a preliminary report. Fertil Steril 1996;65:552-5.
11. Anasti J, Moy E, Kimzey R, George M, Nelson LM. Human follicle fluid vascular endothelial growth factor (VEGF) is correlated with serum LH and follicle fluid progesterone. FASEB J 1996;10:A646.
12. McClure N, Healy D, Rogers PA, Sullivan J, Beaton L, Haning RV Jr., et al. VEGF as a capillary permeability agent in OHSS. Lancet 1994;344:235-6.
13. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicular-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 1996;81:1038-45.